glp-1-directed nmda receptor antagonism for obesity treatment Treating using glucagon-like peptide-1-directed N-methyl-D-aspartate inhibition GLP-1 receptor agonism: a transformative

glp-1-directed nmda receptor antagonism for obesity treatment

glp-1-directed nmda receptor antagonism for obesity treatment Treating using glucagon-like peptide-1-directed N-methyl-D-aspartate inhibition GLP-1 receptor agonism: a transformative

Name: glp-1-directed nmda receptor antagonism for obesity treatment Treating using glucagon-like peptide-1-directed N-methyl-D-aspartate inhibition GLP-1 receptor agonism: a transformative
Brand: wefit.es
SKU: 1580304347
Price: 26.34 USD
Availability: InStock
Rating: 4.4842 (10 reviews)

SKU: 1580304347

4.5

EUR26.34 EUR69.34

Pay in 4 interest-free payments of $6.58 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

H.OlanderssonK.et al (2018)

Psychopharmacology (Berl) 2001;156:1826

This antioxidant has been associated with a delay in the clinical onset of the disease (Table 1) in transgenic mice that express mutant copies of the gene encoding SOD1 (an animal model of ALS) (Gurney et al., 1996)